- Home
- ARDX vs CRON Comparison
ARDX vs CRON Comparison
Compare ARDX & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- CRON
- Stock Information
- Founded
- ARDX 2007
- CRON N/A
- Country
- ARDX United States
- CRON Canada
- Employees
- ARDX N/A
- CRON N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- CRON Medicinal Chemicals and Botanical Products
- Sector
- ARDX Health Care
- CRON Health Care
- Exchange
- ARDX Nasdaq
- CRON Nasdaq
- Market Cap
- ARDX 882.9M
- CRON 809.4M
- IPO Year
- ARDX 2014
- CRON N/A
- Fundamental
- Price
- ARDX $5.13
- CRON $2.60
- Analyst Decision
- ARDX Strong Buy
- CRON
- Analyst Count
- ARDX 9
- CRON 0
- Target Price
- ARDX $10.50
- CRON N/A
- AVG Volume (30 Days)
- ARDX 3.0M
- CRON 2.9M
- Earning Date
- ARDX 10-30-2025
- CRON 11-11-2025
- Dividend Yield
- ARDX N/A
- CRON N/A
- EPS Growth
- ARDX N/A
- CRON N/A
- EPS
- ARDX N/A
- CRON 0.05
- Revenue
- ARDX $386,146,000.00
- CRON $130,282,000.00
- Revenue This Year
- ARDX $17.34
- CRON $19.67
- Revenue Next Year
- ARDX $27.08
- CRON $30.56
- P/E Ratio
- ARDX N/A
- CRON $53.06
- Revenue Growth
- ARDX 83.88
- CRON 28.01
- 52 Week Low
- ARDX $3.21
- CRON $1.60
- 52 Week High
- ARDX $6.84
- CRON $3.16
- Technical
- Relative Strength Index (RSI)
- ARDX 28.38
- CRON 47.79
- Support Level
- ARDX $5.24
- CRON $2.56
- Resistance Level
- ARDX $6.78
- CRON $3.16
- Average True Range (ATR)
- ARDX 0.20
- CRON 0.12
- MACD
- ARDX -0.15
- CRON -0.02
- Stochastic Oscillator
- ARDX 3.01
- CRON 1.61
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About CRON Cronos Group Inc. Common Share
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.